Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1983 Apr;49(4):381–387. doi: 10.1136/hrt.49.4.381

Inhibition of leucocyte migration by stimulated mononuclear cell supernatants from patients with ischaemic heart disease.

S K Das, L D Stein, P J Thebert, R T Reynolds, J T Cassidy
PMCID: PMC481318  PMID: 6830672

Abstract

Leucocyte migration inhibition in patients with ischaemic heart disease was evaluated as an assay for progressive myocardial damage. Abnormal results were observed in 50% of patients with ischaemic cardiac disease. The prevalence of abnormal leucocyte migration inhibition was unrelated to clinical presentation, extent of coronary artery disease, or degree of impairment of left ventricular function. Six of the eight patients with unstable angina pectoris and abnormal leucocyte migration inhibition developed life threatening cardiac complications in the follow-up period compared with five patients with unstable angina and normal tests who developed no complications. A similar association between abnormal leucocyte migration inhibition and complications was not observed in patients with angina pectoris or previous myocardial infarction. Thus, leucocyte migration inhibition may be useful as a prognostic marker in unstable angina and may be an important additional variable to identify a high risk subset.

Full text

PDF
381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clausen J. E. Tuberculin-induced migration inhibition of human peripheral leucocytes in agarose medium. Acta Allergol. 1971 Feb;26(1):56–80. doi: 10.1111/j.1398-9995.1971.tb01399.x. [DOI] [PubMed] [Google Scholar]
  2. Farrell C., Bloth B., Nielsen H., Daugharty H., Lundman T., Svehag S. E. A survey for circulating immune complexes in patients with acute myocardial infarction. Use of a C1q-binding assay with soluble protein A as indicator. Scand J Immunol. 1977;6(12):1233–1240. doi: 10.1111/j.1365-3083.1977.tb00362.x. [DOI] [PubMed] [Google Scholar]
  3. Gazes P. C., Mobley E. M., Jr, Faris H. M., Jr, Duncan R. C., Humphries G. B. Preinfarctional (unstable) angina--a prospective study--ten year follow-up. Prognostic significance of electrocardiographic changes. Circulation. 1973 Aug;48(2):331–337. doi: 10.1161/01.cir.48.2.331. [DOI] [PubMed] [Google Scholar]
  4. Guthrie R. B., Vlodaver Z., Nicoloff D. M., Edwards J. E. Pathology of stable and unstable angina pectoris. Circulation. 1975 Jun;51(6):1059–1063. doi: 10.1161/01.cir.51.6.1059. [DOI] [PubMed] [Google Scholar]
  5. Górski A. J., Dupont B., Hansen J. A., Good R. A. Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro. Proc Natl Acad Sci U S A. 1975 Aug;72(8):3197–3200. doi: 10.1073/pnas.72.8.3197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Schroeder J. S., Lamb I. H., Hu M. Do patients in whom myocardial infarction has been ruled out have a better prognosis after hospitalization than those surviving infarction? N Engl J Med. 1980 Jul 3;303(1):1–5. doi: 10.1056/NEJM198007033030101. [DOI] [PubMed] [Google Scholar]
  7. Sharma R. K., Ahuja R. C., Tandon O. P., Chaturvedi U. C. Leucocyte migration inhibition test in cases of ischaemic heart disease. Br Heart J. 1978 May;40(5):541–546. doi: 10.1136/hrt.40.5.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wartenberg J., Brostoff J. Leucocyte migration inhibition by heart extract and liver mitochondria in patients with myocardial infarction. Br Heart J. 1973 Aug;35(8):845–848. doi: 10.1136/hrt.35.8.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Wartenberg J., Doniach D., Brostoff J., Roitt I. M. Leucocyte migration inhibition with mitochondria in human autoimmune thyroid disorders. Clin Exp Immunol. 1973 Jun;14(2):203–212. [PMC free article] [PubMed] [Google Scholar]
  10. Willerson J. T., Parkey R. W., Bonte F. J., Meyer S. L., Atkins J. M., Stokley E. M. Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of varying etiology. Circulation. 1975 Jun;51(6):1046–1052. doi: 10.1161/01.cir.51.6.1046. [DOI] [PubMed] [Google Scholar]
  11. Willoughby E. W., Dupont B., Hansen J. A., Good R. A. The indirect assay for leukocyte migration inhibitory factor (LIF)--standardization and the effect of pH. J Immunol Methods. 1978;22(1-2):99–110. doi: 10.1016/0022-1759(78)90062-5. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES